Amber Salzman, Ph.D.
Advertisement
Amber Salzman, Ph.D., is the president and CEO of Ohana Biosciences.
Articles by Amber Salzman, Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
4
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
5